ALT 0.00% 0.5¢ analytica limited

wiseowl research - 7.6c buy recommendation

  1. 23,832 Posts.
    lightbulb Created with Sketch. 725
    http://www.analyticamedical.com/downloads/2013/20130828-Wiseowl-Analytica-ALT-Aug2013.pdf

    Wise-owl continues to recommend medical device company Analytica (ALT) with a 'speculative buy' as it moves into the growing m-Health market.

    On the verge of selling its female incontinence device PeriCoach.

    Global market worth in excess of $5 billion.

    PeriCoach allows Analytica to enter the fast growing m-Health market.

    Revised target of 7.6c, upside of more than 260% from current levels.
 
watchlist Created with Sketch. Add ALT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.